{
  "title": "SPAC Week II: Canndoc And The Parent Company",
  "author": "Seeking Alpha",
  "dc:creator": "Seeking Alpha",
  "enclosure": "",
  "guid": "f610a122-7118-11eb-86d0-6b41b1a6769f",
  "pubDate": "Wed, 17 Feb 2021 13:00:00 GMT",
  "link": "https://the-cannabis-investing-podcast.sounder.fm",
  "description": "<p>Michael Auerbach returns to discuss Subversive's recent deal with leading Israel cannabis company, InterCure and gives an update on The Parent Company. Why Subversive pivoted from a REIT to a SPAC, Canndoc's compelling financials, brands and trading on Nasdaq. Opportunity in GRAMF and other US players still trading at a discount.\nLearn more about your ad choices. Visit megaphone.fm/adchoices</p>",
  "content:encoded": "<p>Michael Auerbach returns to discuss Subversive's recent deal with leading Israel cannabis company, InterCure and gives an update on The Parent Company. Why Subversive pivoted from a REIT to a SPAC, Canndoc's compelling financials, brands and trading on Nasdaq. Opportunity in GRAMF and other US players still trading at a discount.\nLearn more about your ad choices. Visit megaphone.fm/adchoices</p>",
  "itunes:title": "SPAC Week II: Canndoc And The Parent Company",
  "itunes:image": "",
  "itunes:author": "Seeking Alpha",
  "itunes:duration": "00:51:00",
  "itunes:explicit": false,
  "itunes:summary": "Michael Auerbach returns to discuss Subversive's recent deal with leading Israel cannabis company, InterCure and gives an update on The Parent Company. Why Subversive pivoted from a REIT to a SPAC, Canndoc's compelling financials, brands and trading on Nasdaq. Opportunity in GRAMF and other US players still trading at a discount.\nLearn more about your ad choices. Visit megaphone.fm/adchoices",
  "itunes:episodeType": "full",
  "podcast:person": "Seeking Alpha",
  "podcast:transcript": "",
  "podcast:guid": "f610a122-7118-11eb-86d0-6b41b1a6769f"
}